With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Today, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an intriguing new partnership with the Dow Jones Indexes – a new line of stock market indices. These new indices – led by the flagship Dow Jones Global Fund 50 Index – will measure the performance of the largest companies worldwide that support the Global Fund’s mission. They have already concluded licensing arrangements with Deutsche Bank and the National Bank of Abu Dhabi to market the indices with investors. And a portion of the indices’ royalties will help fund the Global Fund’s ongoing programs. This won’t generate huge sums of money, but what an interesting win-win idea for generating interest in the Global Fund’s programs while enhancing the brand quality of the listed companies’. And who knows, maybe the Global Fund 50 Index will take off and pave the way for other development-friendly stock market indices.
CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.
The Global Fund’s Office of the Inspector General (OIG) released a new audit report on Wambo.org, its online procurement platform for drugs and other health commodities. The headline: despite high marks from its users, Wambo.org is not yet on track to deliver the projected savings. But more than the headline, a close read of the report narrative helps us understand why reality does not yet reflect the Global Fund’s optimistic assumptions—and, reading between the lines, suggests three important lessons for the Global Fund and other international funders
This week, the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria was set to name the organization’s new executive director. Instead, after the shortlist of candidates appeared in the New York Times, some in the global health community anonymously expressed concerns about the selection process and its results—and the Board abruptly announced it would restart the process from scratch. As the executive director search reboots, I am looking for candidates that have clarity, concrete plans, and capacity to make progress in three areas—the big 3—that are essential to the Fund’s survival: results, efficiency, and money.